Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 29

1.

Cerebrospinal Fluid and Plasma Biomarkers do not Differ in the Presenile and Late-Onset Behavioral Variants of Frontotemporal Dementia.

Marelli C, Hourregue C, Gutierrez LA, Paquet C, Menjot de Champfleur N, De Verbizier D, Jacob M, Dubois J, Maleska AM, Hirtz C, Navucet S, Bennys K, Dumurgier J, Cognat E, Berr C, Magnin E, Lehmann S, Gabelle A.

J Alzheimers Dis. 2020 Feb 21. doi: 10.3233/JAD-190378. [Epub ahead of print]

PMID:
32083577
2.

Brain 18FDG-PET pattern in patients with alcohol-related cognitive impairment.

Clergue-Duval V, Questel F, Azuar J, Paquet C, Cognat E, Amami J, Queneau M, Dereux A, Barré T, Bellivier F, Farid K, Vorspan F.

Eur J Nucl Med Mol Imaging. 2020 Feb;47(2):281-291. doi: 10.1007/s00259-019-04487-1. Epub 2019 Aug 19.

PMID:
31428832
3.

Intracranial Extension of Extracranial Vertebral Dissection Is Associated With an Increased Risk of Ischemic Events.

Di Meglio L, Mazighi M, Reiner P, Peres R, Guichard JP, Labeyrie MA, Debette S, Chabriat H, Cognat E.

Stroke. 2019 Aug;50(8):2231-2233. doi: 10.1161/STROKEAHA.119.025227. Epub 2019 Jun 21.

PMID:
31221053
4.

What is the clinical impact of cerebrospinal fluid biomarkers on final diagnosis and management in patients with mild cognitive impairment in clinical practice? Results from a nation-wide prospective survey in France.

Cognat E, Mouton Liger F, Troussière AC, Wallon D, Dumurgier J, Magnin E, Duron E, Gabelle A, Croisile B, de la Sayette V, Jager A, Blanc F, Bouaziz-Amar E, Miguet-Alfonsi C, Quillard M, Schraen S, Philippi N, Beaufils E, Pasquier F, Hannequin D, Robert P, Hugon J, Paquet C; ePLM network.

BMJ Open. 2019 May 30;9(5):e026380. doi: 10.1136/bmjopen-2018-026380.

5.

Biomarker profiles of Alzheimer's disease and dynamic of the association between cerebrospinal fluid levels of β-amyloid peptide and tau.

Lafirdeen ASM, Cognat E, Sabia S, Hourregue C, Lilamand M, Dugravot A, Bouaziz-Amar E, Laplanche JL, Hugon J, Singh-Manoux A, Paquet C, Dumurgier J.

PLoS One. 2019 May 14;14(5):e0217026. doi: 10.1371/journal.pone.0217026. eCollection 2019.

6.

CSF level of β-amyloid peptide predicts mortality in Alzheimer's disease.

Boumenir A, Cognat E, Sabia S, Hourregue C, Lilamand M, Dugravot A, Bouaziz-Amar E, Laplanche JL, Hugon J, Singh-Manoux A, Paquet C, Dumurgier J.

Alzheimers Res Ther. 2019 Mar 28;11(1):29. doi: 10.1186/s13195-019-0481-4.

7.

Biomarkers of Alzheimer's disease in older and oldest old patients.

Lilamand M, Cognat E, Goutagny S, Hourregue C, Hugon J, Dumurgier J, Paquet C.

Geriatr Psychol Neuropsychiatr Vieil. 2019 Mar 1;17(1):65-72. doi: 10.1684/pnv.2019.0779. Review.

PMID:
30907369
8.

Blood-Based Kinase Assessments in Alzheimer's Disease.

Hugon J, Mouton-Liger F, Cognat E, Dumurgier J, Paquet C.

Front Aging Neurosci. 2018 Nov 14;10:338. doi: 10.3389/fnagi.2018.00338. eCollection 2018. Review.

9.

Increased PKR level in human CADASIL brains.

Cognat E, Tible M, Methnani I, Chabriat H, Adle-Biassette H, Hugon J, Paquet C.

Virchows Arch. 2018 Dec;473(6):771-774. doi: 10.1007/s00428-018-2425-y. Epub 2018 Aug 2.

PMID:
30073405
10.

Distribution of Cerebrospinal Fluid Biomarker Profiles in Patients Explored for Cognitive Disorders.

Paquet C, Bouaziz-Amar E, Cognat E, Volpe-Gillot L, Haddad V, Mahieux F, Dekimeche S, Defontaines B, Chabriat H, Belin C, Texeira A, Goutagny S, Questel F, Azuar J, Sellier PO, Laplanche JL, Hugon J, Dumurgier J.

J Alzheimers Dis. 2018;64(3):889-897. doi: 10.3233/JAD-180240.

PMID:
29966201
11.

Efficacy of Endovascular Therapy in Acute Ischemic Stroke Depends on Age and Clinical Severity.

Le Bouc R, Clarençon F, Meseguer E, Lapergue B, Consoli A, Turc G, Naggara O, Duong DL, Servan J, Reiner P, Labeyrie MA, Fisselier M, Blanc R, Farhat W, Pires C, Zuber M, Obadia M, Mazighi M, Pico F, Mas JL, Amarenco P, Samson Y; Paris Stroke Consortium.

Stroke. 2018 Jul;49(7):1686-1694. doi: 10.1161/STROKEAHA.117.020511. Epub 2018 Jun 18.

PMID:
29915120
12.

Visibility of Blood Flow on Optical Coherence Tomography Angiography in a Case of Branch Retinal Artery Occlusion.

Bonnin S, Krivosic V, Cognat E, Tadayoni R.

J Ophthalmic Vis Res. 2018 Jan-Mar;13(1):75-77. doi: 10.4103/jovr.jovr_13_17.

13.

Elevated ALS Biomarker Levels in CSF of a FTD Patient at the Presymptomatic Stage of ALS.

Cognat E, De Schaepdryver M, Hugon J, Poesen K, Paquet C.

Alzheimer Dis Assoc Disord. 2018 Apr-Jun;32(2):156-157. doi: 10.1097/WAD.0000000000000222. No abstract available.

PMID:
29189300
14.

Endovascular management of extracranial occlusions at the hyperacute phase of stroke with tandem occlusions.

Labeyrie MA, Ducroux C, Civelli V, Reiner P, Cognat E, Aymard A, Bisdorff A, Saint-Maurice JP, Houdart E.

J Neuroradiol. 2018 May;45(3):196-201. doi: 10.1016/j.neurad.2017.10.003. Epub 2017 Nov 11.

PMID:
29132938
15.

Differential diagnosis between sarcoidosis and granulomatosis with polyangiitis in a patient with leptomeningeal, cavernous sinus and pituitary lesions.

Marques C, Roriz M, Chabriat H, Buffon-Porcher F, Cognat E.

QJM. 2017 Oct 1;110(10):691-692. doi: 10.1093/qjmed/hcx135. No abstract available.

PMID:
29025147
16.

Neurosarcoidosis: leptomeninigeal, cavernous sinus and pituitary involvement.

Bicart-Sée L, Roriz M, Chabriat H, Buffon-Porcher F, Cognat E.

QJM. 2017 Jun 1;110(6):397-398. doi: 10.1093/qjmed/hcx037. No abstract available.

PMID:
28186582
17.

Reducing Timp3 or vitronectin ameliorates disease manifestations in CADASIL mice.

Capone C, Cognat E, Ghezali L, Baron-Menguy C, Aubin D, Mesnard L, Stöhr H, Domenga-Denier V, Nelson MT, Joutel A.

Ann Neurol. 2016 Mar;79(3):387-403. doi: 10.1002/ana.24573. Epub 2016 Feb 10.

18.

[Exploring the facets of perinatal care].

Cognat É.

Rev Infirm. 2015 Apr;(210):29. doi: 10.1016/j.revinf.2015.01.011. French.

PMID:
26145423
19.

[Continuity of care for patients after postoperative recovery room stay].

Cognat É.

Rev Infirm. 2015 Feb;(208):53-4. doi: 10.1016/j.revinf.2014.11.019. Epub 2015 Feb 2. French. No abstract available.

PMID:
26144836
20.

Potassium channelopathy-like defect underlies early-stage cerebrovascular dysfunction in a genetic model of small vessel disease.

Dabertrand F, Krøigaard C, Bonev AD, Cognat E, Dalsgaard T, Domenga-Denier V, Hill-Eubanks DC, Brayden JE, Joutel A, Nelson MT.

Proc Natl Acad Sci U S A. 2015 Feb 17;112(7):E796-805. doi: 10.1073/pnas.1420765112. Epub 2015 Feb 2.

Supplemental Content

Loading ...
Support Center